How a hatemonger used a schoolgirl to concoct a stabbing story to create unrest in Honnavar

Mangaluru, May 6: Amidst delay in repatriation of Kannadigas stuck in Gulf countries including UAE and Saudi Arabia, on behalf of the office bearers, the executive committee and members of the Bearys Chamber of Commerce & Industry, its president Mr S M Rasheed Haji and executive committee member U T Ifthikar Ali today (May 6) called on authorities concerned in Dakshina Kannada to persuade them to follow up with the State and Central level authorities.  

The duo met Nalin Kumar Kateel, Dakshina Kannada MP, who immediately contacted Pralhad Joshi, Minister of Parliamentary Affairs, over phone and urged him to take up the issue with the external affairs ministry. Mr Joshi told Mr Kateel that efforts are still underway to bring back Kannadigas stranded in Gulf countries. However flights schedules are yet to be finalised.

The duo then met Kota Srinivas Poojary, district in-charge minister, who said that the government is prepared to handle the repatriation flights and passengers. 

The duo also met IAS officer Rahul Shinde, who is in-charge of affairs related to international passengers coming to Dakshina Kannada amid covid-19 crisis. Meanwhile, Zakariya Jokatte, president of Jubail unit of BCCI, spoke to Mr Shindhe over phone.

The official explained that the govt has made elaborate arrangements to conduct medical test of passengers on arrival at the Mangaluru International Airport. 

The passengers will be categorised into A, B and C groups depending on their symptoms and co-morbid conditions. The category A passengers (symptomatic passengers) will be sent to isolation hospitals which may be Covid care centres. Category B passengers (asymptomatic but suffering from co-morbid conditions) will be quarantined at hotels, hostels, guest houses etc. Category C passengers (asymptomatic and healthy) will be home quarantined.

The minister and official also sought BCCI’s cooperation in handling the situation. 

Quarantine accommodation facility 

Yenepoya group has already offered two of their hotels as quarantine accommodation and promised to offer one more.  Entrepreneur U Kanachur Monu and many others too have offered their hotels as quarantine accommodation in Mangaluru. 

District administration has asked Treebo, a hotel aggregator to list such willing facilities on their website.

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

May 27: At a time when India is struggling with the deadly coronavirus, huge swarms of locusts in many states has bought nightmares to the farmers.

Experts warn of extensive crop losses if authorities fail to curb the fast-spreading swarms by June when monsoon rains spur rice, cane, corn, cotton, and soybean sowing.

Locusts entered India after traveling from Africa through Yemen, Iran and Pakistan.

After massive devastation in Pakistan, t swarms of locusts entered India through Rajasthan and Gujarat. The number is so large that the farmers and authorities are feeling helpless in tackling the threat.

The situation has become more alarming as the locusts is spreading across the country at an extremely fast rate. After badly affecting the crops in Rajasthan, Gujarat, Maharashtra, and Madhya Pradesh, the swarm of locust have now entered Uttar Pradesh.

In Rajasthan alone, the locust attack has damaged 5 lakh hectares of crop and nearly 17 districts of Madhya Pradesh have also seen their terror. Earlier from May 2019 to February 2020, too, the locust swarms entered India several times.

Speaking on the current situation, Dr Ram Pravesh, District Agricultural Officer, Agra, Uttar Pradesh said the Department of Agriculture is working with farmers in dealing with the situation. He urged the farmers to inform their Mandal Krishi Adhikari if they require any help.

India's largest-ever locust attack was in 1993 when more than three lakh hectares of cultivated land were completely destroyed.

Earlier in 2020, farmers salvaged their wheat and oilseed crops from a previous locust scourge.